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This study aimed to determine the effect of reducing the dietary linoleic acid (LA) intake 33 from ~5% to <2.5% energy (%E) on n-3 long chain PUFA (LCPUFA) status in humans.
34
Thirty-six participants followed a <2.5%E LA diet for 4 weeks. Nutrient intakes were 35 estimated from diet diaries and blood samples were collected for assessment of fatty acid 36 composition in plasma and erythrocyte phospholipids. LA intakes were reduced from 4.6%E 37 to 2%E during the low LA intervention (P<0.001) while n-3 LCPUFA intakes were 38 unchanged. LA and total n-6 PUFA content of plasma and erythrocyte phospholipids were 39 significantly reduced after the low LA diet phase (P<0.001). The n-3 LCPUFA content was 40 significantly increased in plasma phospholipids after the low LA diet compared to baseline 41 (6.22% vs 5.53%, P<0.001). These data demonstrate that reducing LA intake for 4 weeks 42 increases n-3 LCPUFA status in humans in the absence of increased n-3 LCPUFA intake. The health impacts of this marked change in dietary fatty acid composition are unclear, 53 however concerns have been raised that this substantial increase in LA intake could have 54 negative impacts on cardiovascular and metabolic health [3, 4] . This suggestion is based on 55 the biochemical properties of the n-6 PUFA, since the long-chain derivative of LA,
56
arachidonic acid (AA), gives rise to pro-inflammatory and pro-thrombotic compounds [5] ,
57
and the fact that high circulating concentrations of n-6 PUFA have been implicated in an 58 increased risk of inflammatory and allergic conditions in epidemiological studies [6] . While 59 data from humans directly linking increased LA intake and disease are lacking, data from the 60 Sydney heart study recently published by Ramsden and colleagues provided the first evidence 61 from a randomized controlled trial that a dietary intervention in which saturated fats were 62 replaced by concentrated sources of LA (as opposed to a mixture of n-6 and n-3 PUFA) was 63 associated with an increased risk of death from coronary heart disease, raising renewed 64 concerns about the impact of n-6 PUFA on human health [7] . LA competes with the short-chain n-3 PUFA alpha-linolenic acid (ALA) for the enzymes 67 required for conversion to their respective long-chain derivatives and for incorporation into 68 the plasma membrane [8] . Consequently, high LA diets may limit the capacity of increases in dietary n-3 PUFA intake to improve n-3 PUFA status [9] . Given that several bioactive 70 mediators derived from n-3 LCPUFA are less potent in their inflammatory actions than their
71
AA-derived analogs [10] , and others actually have potent inflammation-resolving [11] or 72 neuroprotective properties [12] , this competition has the potential to contribute to negative 73 health outcomes.
75
Current strategies to improve n-3 LCPUFA status of the population have focused almost 76 exclusively on increasing dietary n-3 LCPUFA intake, via increased consumption of oily fish 77 or through fish oil supplementation [13] . However, many Australians struggle to achieve 78 regular fish intake [14] and dwindling marine resources have raised questions about the long-
79
term sustainability of this approach [15] . Given the competition that exists between n-6 and 80 n-3, it has been suggested that lowering the LA content of the diet has the potential to both 81 limit the production of n-6 derived pro-inflammatory mediators and enhance the biological 82 efficacy of n-3 LCPUFA consumed in the diet. However, the ubiquity of LA in the food 83 supply, particularly in pre-prepared and take-away foods, makes any attempt to reduce the n-
84
6 PUFA intake of free-living humans challenging.
86
We previously designed a low n-6 PUFA diet, in which we reduced the LA content of the diet 87 from ~5% to ~2%E by replacing standard plant-based oils and spreads with low n-6 PUFA 88 alternatives (Macadamia oil and butter), and limiting intake of processed and take-away 89 foods which utilize high n-6 PUFA oils [16] . Importantly, we showed that the reduction in
90
LA intake could be achieved while still adhering to the national dietary recommendations saturated fat intake of less than 10%E [16] . The aim of the present study was to determine 93 whether following this low LA diet for a 4 week period would result in reduced n-6 PUFA The low LA diet was based on the diet previously designed by our group [16] and aimed to 140 achieve an LA intake of ~2%E whilst maintaining saturated fat intake at <10%E and not were provided with written materials identifying low LA alternatives for commonly 148 consumed foods to assist them in making appropriate food choices when eating out or 149 purchasing take away foods. A list of low LA recipes was also provided to participants.
150
These resources were adapted from those produced for participants in a previous low n-6
151
PUFA trial [18] . All participants were contacted by telephone, email or social networking The fatty acid composition of plasma and erythrocyte phospholipids was analysed using gas 171 chromatography as described in detail previously [19] . limit of detection (0.05%) were allocated a set value of 0.025% (half the limit of detection).
184
All solvents used for extraction and separation contained 0.005% (w/v) of the antioxidant, 185 butylated hydroxyanisol (BHA). All solvents used in this study were purchased from Ajax Thirty-six healthy participants (male=12, female=24) were recruited to the study. Of these,
201
three subjects withdrew from the study during the 2 week control phase before the low LA
202
PUFA diet commenced, due either to an inability to provide a blood sample (n=1) or because Table 1 . There was no change in body weight or BMI after the 4 weeks on the low LA diet 208 compared to weight at baseline (data not shown).
210
Dietary data
211
The mean dietary intakes of energy, macronutrients, n-6 and n-3 PUFA during the 2 week 212 control phase and during the 4-week dietary intervention are presented in Table 2 .
213
Participants consumed significantly less total energy and total fat during the low LA diet 214 phase compared to baseline (P<0.05). There was no significant difference, however, in the Median plasma phospholipid fatty acids at baseline and following 4 weeks on the low LA 227 diet are presented in Table 3 . After 4 weeks on the low LA diet, there was a significant LCPUFA (P<0.001) were all significantly increased after 4 weeks on the low LA diet (Table   233 3). There was no difference in the ALA content of the plasma phospholipids after 4 weeks on 234 the low LA diet (Table 3) .
236
Erythrocyte phospholipid fatty acid profile
237
Median erythrocyte phospholipid fatty acids at baseline and following 4 weeks on the low LA 238 diet are presented in Table 4 . Consistent with the plasma phospholipids, after 4 weeks on the 239 low LA diet, there was a significant decrease in both LA and total n-6 PUFA content of This study has demonstrated that it is feasible to reduce LA intake in the diet from 4.6%E to 249 2%E in free-living humans. This is only the second study to demonstrate that n-6 PUFA participants with a low n-6 PUFA diet for 12 weeks [18] , and consistent with the hypothesis 266 that high n-6 diets can limit uptake of dietary n-3 LCPUFA into tissues. The finding that The unintentional decrease in ALA intake in our trial was likely due to the fact that many key 293 dietary sources of ALA (canola oil, nuts and seeds) are also relatively high in LA and were 294 not permitted during the low LA dietary intervention. In addition, the macadamia oil and 295 butter that were used as substitutes for standard vegetable oils and spreads contain very low 296 levels of ALA. This was avoided in the MacIntosh trial by providing a small amount of 297 ground flaxseed to participants during the low n-6 dietary intervention in order to maintain 298 average US ALA intake despite a reduction in high LA vegetable oils that are also major 299 sources of n-3 ALA (e.g. canola, soy) [18] . Clearly, the magnitude of change in n-3 LCPUFA status in this 4-week trial is much less than 320 achieved by directly supplementing the diet with n-3 LCPUFA. Therefore, the potential for 321 low LA diets to provide a substitute for n-3 LCPUFA supplementation to raise n-3 LCPUFA 322 status may be limited. However, recent evidence suggests that high n-6 LA intakes have the 323 potential to produce negative health effects through the production of bioactive lipid 324 mediators derived from n-6 LA (e.g. hydroperoxy-and hydroxy-fatty acids), i.e. independent 325 of n-3 LCPUFA status [26] [27] [28] . It is therefore possible that low n-6 LA diets may be 326 associated with clinical benefits in spite of relatively modest effects on n-3 LCPUFA status.
327
For example, the bioactive n-6 LA metabolite leukotoxin is reported to contribute to tissue 328 damage [29, 30] , and the n-6 LA metabolites 9-and 13-HODE are reported to have pro- 
CONCLUSIONS

339
We have demonstrated that it is possible to reduce dietary LA intake to ~2%E in a free-living 340 human population with no provision of foodstuffs apart from a highly monounsaturated oil 341
16
(macadamia oil) and butter, and without causing an increase in total fat intake. The low LA 342 diet reduced LA and total n-6 PUFA content of plasma and erythrocyte phospholipids.
343
Importantly, the low LA diet also increased the n-3 LCPUFA content of the plasma 344 phospholipids, in the absence of any increase in n-3 LCPUFA intake, almost certainly due to 345 higher incorporation of dietary n-3 LCPUFA. These data support the hypothesis that short- 
